FIELD: medicine, hematology. SUBSTANCE: method involves analysis in activated partial thromboplastin test using protein C as activator and assay of coagulation time. Coagulation time of mixture of patient analyzing plasma with resistance to activated protein is determined after addition of activator of protein C to this mixture and after addition of distilled water. Then index R as ratio of mixture coagulation with addition of activator of protein C to time of mixture coagulation with addition of distilled water is calculated. Thrombophilia is diagnosed in value of this index less 2.1. Method provides the enhancement of thrombophilia diagnosis precision determined by resistance of factor V to activated protein C. EFFECT: improved method of diagnosis. 3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DETERMINING THROMBOPHILIA CAUSED BY RESISTANCE OF V FACTOR TO ACTIVATED PROTEIN C | 1996 |
|
RU2129282C1 |
METHOD FOR CONTROL OF SUBSTITUTIONAL THERAPY EFFICIENCY AT DVS- SYNDROME | 2000 |
|
RU2190855C2 |
METHOD FOR DIAGNOSING THE CASES OF THROMBOPHILIA CAUSED BY HIGH ACTIVITY LEVEL OF COAGULATION FACTOR VIII | 2002 |
|
RU2227918C1 |
METHOD FOR DIAGNOSING ANTIPHOSPHOLIPID SYNDROME | 1995 |
|
RU2104550C1 |
METHOD FOR DETERMINING LUPUS ERYTHEMATOSUS ANTICOAGULANT AVAILABILITY | 1999 |
|
RU2181203C2 |
HEPARIN CONCENTRATION DETERMINATION METHOD | 2003 |
|
RU2249819C2 |
METHOD OF DYSPLASMINOGENEMIA DIAGNOSTICS | 2006 |
|
RU2336529C2 |
METHOD FOR PREECLAMPSIA PREDICTION IN PREGNANT WOMEN WITH MUTATION OF FACTOR V LEIDEN 1691 GENE OF G/A AND A/A GENOTYPE | 2016 |
|
RU2636228C1 |
METHOD OF PROTEIN C ACTIVATOR PREPARING | 2000 |
|
RU2184976C1 |
METHOD OF QUANTITATIVE DETERMINATION OF FIBRINOGENS IN BLOOD PLASMA | 0 |
|
SU1146002A1 |
Authors
Dates
2003-05-27—Published
2001-05-24—Filed